Next Article in Journal
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix
Next Article in Special Issue
Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
Previous Article in Journal
Simultaneous Deletion of Virulence Factors and Insertion of Antigens into the Infectious Laryngotracheitis Virus Using NHEJ-CRISPR/Cas9 and Cre–Lox System for Construction of a Stable Vaccine Vector
Previous Article in Special Issue
SLAM Family Receptor Signaling in Viral Infections: HIV and Beyond
 
 
Article

Article Versions Notes

Vaccines 2019, 7(4), 208; https://doi.org/10.3390/vaccines7040208
Action Date Notes Link
article xml file uploaded 6 December 2019 09:39 CET Original file -
article xml uploaded. 6 December 2019 09:39 CET Update https://www.mdpi.com/2076-393X/7/4/208/xml
article pdf uploaded. 6 December 2019 09:39 CET Version of Record https://www.mdpi.com/2076-393X/7/4/208/pdf
article html file updated 6 December 2019 09:41 CET Original file -
article html file updated 30 December 2019 18:13 CET Update -
article html file updated 14 February 2020 16:24 CET Update -
article html file updated 19 July 2022 22:21 CEST Update https://www.mdpi.com/2076-393X/7/4/208/html
Back to TopTop